Angiodynamics (ANGO) Operating Income (2010 - 2026)
Angiodynamics' (ANGO) quarterly Operating Income came in at -$10.2 million in Q2 2026, down 76.14% YoY from -$42.7 million in Q2 2025, and up 21.28% on a QoQ basis from -$13.0 million in Q1 2026.
Angiodynamics (ANGO) Operating Income (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Operating Income data on file, last reported at -$10.2 million in Q2 2026.
- Quarterly Operating Income fell 76.14% year-over-year to -$10.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$39.9 million (changed 0.07% YoY) and the FY2026 annual result came in at -$39.9 million, changed 0.07% from the prior year.
- Operating Income advanced to -$10.2 million in Q2 2026, from -$13.0 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $35.0 million in Q3 2023 to a low of -$199.9 million in Q1 2024.
- A 5-year average of -$18.6 million and a median of -$10.4 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income surged 363.36% — and 2024, when it slumped 2138.98%.
- Tracing ANGO's Operating Income over 5 years: stood at -$8.1 million in 2022, then tumbled by 61.68% to -$13.1 million in 2023, then grew by 15.44% to -$11.1 million in 2024, then surged by 44.79% to -$6.1 million in 2025, then slumped by 66.45% to -$10.2 million in 2026.
- The last three Operating Income figures came in at -$10.2 million (Q2 2026), -$13.0 million (Q1 2026), and -$6.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.49 Bn | 129.28 Bn | 1.96 Bn | 971.90 Mn |
| 2 | Becton Dickinson | 52.54 Bn | 51.67 Bn | 2.32 Bn | 663.00 Mn |
| 3 | Alcon | 35.71 Bn | 34.35 Bn | 1.68 Bn | 11.00 Mn |
| 4 | Resmed | 33.80 Bn | 32.33 Bn | 861.22 Mn | 448.71 Mn |
| 5 | Medline | 29.08 Bn | 26.40 Bn | 2.22 Bn | 395.00 Mn |
| 6 | West Pharmaceutical Services | 24.96 Bn | 24.52 Bn | 329.20 Mn | 179.10 Mn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | 181.00 Mn |
| 8 | Cooper Companies | 14.82 Bn | 14.68 Bn | 735.40 Mn | -31.00 Mn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 217.00 Mn |
| 10 | Angiodynamics | 651.13 Mn | 597.26 Mn | 46.77 Mn | -10.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -10.20 Mn |
| Feb 28, 2026 | -12.95 Mn |
| Nov 30, 2025 | -6.13 Mn |
| Aug 31, 2025 | -10.66 Mn |
| May 31, 2025 | -5.79 Mn |
| Feb 28, 2025 | -9.97 Mn |
| Nov 30, 2024 | -11.09 Mn |
| Aug 31, 2024 | -13.10 Mn |
| May 31, 2024 | -14.45 Mn |
| Feb 29, 2024 | -199.90 Mn |
| Nov 30, 2023 | -13.12 Mn |
| Aug 31, 2023 | 35.03 Mn |
| May 31, 2023 | -20.84 Mn |
| Feb 28, 2023 | -8.93 Mn |
| Nov 30, 2022 | -8.12 Mn |
| Aug 31, 2022 | -13.30 Mn |
| May 31, 2022 | -6.40 Mn |
| Feb 28, 2022 | -5.30 Mn |
| Nov 30, 2021 | -8.68 Mn |
| Aug 31, 2021 | -8.10 Mn |